Your browser doesn't support javascript.
loading
Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance.
Stejskal, Pavel; Goodarzi, Hani; Srovnal, Josef; Hajdúch, Marián; van 't Veer, Laura J; Magbanua, Mark Jesus M.
Afiliación
  • Stejskal P; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University and University Hospital in Olomouc, Olomouc, 779 00, Czech Republic. pavel.stejskal@upol.cz.
  • Goodarzi H; Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, 94158, USA. pavel.stejskal@upol.cz.
  • Srovnal J; Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, 94158, USA.
  • Hajdúch M; Department of Urology, University of California San Francisco, San Francisco, CA, 94158, USA.
  • van 't Veer LJ; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University and University Hospital in Olomouc, Olomouc, 779 00, Czech Republic.
  • Magbanua MJM; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University and University Hospital in Olomouc, Olomouc, 779 00, Czech Republic.
Mol Cancer ; 22(1): 15, 2023 01 21.
Article en En | MEDLINE | ID: mdl-36681803

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ácidos Nucleicos Libres de Células / Células Neoplásicas Circulantes / Neoplasias Tipo de estudio: Prognostic_studies / Screening_studies Límite: Humans Idioma: En Revista: Mol Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: República Checa

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ácidos Nucleicos Libres de Células / Células Neoplásicas Circulantes / Neoplasias Tipo de estudio: Prognostic_studies / Screening_studies Límite: Humans Idioma: En Revista: Mol Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: República Checa